LJM716 in Japanese patients with head and neck squamous cell carcinoma or HER2-overexpressing breast or gastric cancer

Takahashi, S; Kobayashi, T; Tomomatsu, J; Ito, Y; Oda, H; Kajitani, T; Kakizume, T; Tajima, T; Takeuchi, H; Maacke, H; Esaki, T

Takahashi, S (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Med Oncol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017; 79 (1): 131

Abstract

Human epidermal growth factor receptor 3 (HER3) has been identified as an important component of many receptor tyrosine kinase-driven cancers. LJM716 ......

Full Text Link